je.st
news
UPDATE 1-UK cost agency queries value of $700,000-a-year Alexion drug
2016-02-18 12:56:58| Biotech - Topix.net
An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds a year may be worth using in babies with a rare disorder but does not represent good value for all patients, Britain's healthcare cost watchdog said. Kanuma is designed for treating lysosomal acid lipase deficiency, a rare inherited genetic disease in which fats build up in cells.
Tags: cost
update
drug
agency
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||